- Home
- Publications
- Publication Search
- Publication Details
Title
Catch me if you can: how AML and its niche escape immunotherapy
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-24
DOI
10.1038/s41375-021-01350-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
- (2021) G. W. K. Moore et al. Nature Communications
- Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome
- (2021) Amany Kamal et al. Oncology Letters
- Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
- (2021) Luise Müller et al. Frontiers in Cell and Developmental Biology
- Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
- (2021) Rongqun Guo et al. Biomarker Research
- High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
- (2021) Anne-Sophie Chretien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
- (2021) Lauren Giuffrida et al. Nature Communications
- Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study
- (2020) Naval G. Daver et al. BLOOD
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
- (2020) Mark P. Chao et al. Frontiers in Oncology
- Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML
- (2020) Yoko Tabe et al. Frontiers in Oncology
- Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells
- (2020) Jayna J Mistry et al. HAEMATOLOGICA
- Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML).
- (2020) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting CD33 in chemoresistant AML patient-derived xenografts by CAR-CIK cells engineered with an optimized Sleeping Beauty transposon version
- (2020) Maria Caterina Rotiroti et al. MOLECULAR THERAPY
- Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
- (2020) Valerie Barbier et al. Nature Communications
- Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
- (2020) D. Ciardiello et al. ANNALS OF ONCOLOGY
- Palmitoylated proteins on AML-derived extracellular vesicles promote myeloid-derived suppressor cell differentiation via TLR2/Akt/mTOR signaling
- (2020) Sehmus Tohumeken et al. CANCER RESEARCH
- Characterization of a Novel FLT3 BiTE® Antibody Construct for the Treatment of Acute Myeloid Leukemia
- (2020) Bettina Brauchle et al. MOLECULAR CANCER THERAPEUTICS
- Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
- (2020) Silvia Arcangeli et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
- (2020) Yuhui Yang et al. Frontiers in Immunology
- Risk associated alterations in marrow T cells in pediatric leukemia
- (2020) Jithendra Kini Bailur et al. JCI Insight
- Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
- (2020) Geoffrey L Uy et al. BLOOD
- Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells
- (2020) Liangshun You et al. Frontiers in Immunology
- Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
- (2020) Pinar Ataca Atilla et al. Journal for ImmunoTherapy of Cancer
- Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
- (2020) Samanta Romina Zanetti et al. Journal for ImmunoTherapy of Cancer
- Targeting CXCR4 in AML and ALL
- (2020) Daniel Cancilla et al. Frontiers in Oncology
- Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways
- (2020) Saeid Taghiloo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models
- (2020) Xiaoxiao He et al. JOURNAL OF CLINICAL INVESTIGATION
- Monitoring TIGIT/DNAM-1 and PVR/PVRL2 immune checkpoint's expression levels in allogeneic stem cell transplantation for acute myeloid leukemia
- (2019) Norimichi Hattori et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors
- (2019) Mateusz Rytelewski et al. Journal for ImmunoTherapy of Cancer
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
- (2019) Cristina Toffalori et al. NATURE MEDICINE
- A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
- (2019) Ninib Baryawno et al. CELL
- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
- (2019) Anna M. Paczulla et al. NATURE
- Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support
- (2019) Mitra Azadniv et al. LEUKEMIA
- Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
- (2019) Farah Kouzi et al. ONCOGENE
- The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective
- (2019) Dimitrios Mougiakakos Frontiers in Oncology
- Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML
- (2018) Delfim Duarte et al. Cell Stem Cell
- CD8 + T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients
- (2018) Mengjie Wang et al. CLINICAL IMMUNOLOGY
- PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts
- (2018) Christopher R. Marlein et al. LEUKEMIA
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators
- (2018) Stephanie Binder et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia
- (2018) Jyoti Naik et al. HAEMATOLOGICA
- Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
- (2018) Hauke Stamm et al. MAMMALIAN GENOME
- Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
- (2018) Aroa Baragaño Raneros et al. Oncotarget
- Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
- (2018) Matthew J. Christopher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival
- (2018) Giulia Corradi et al. Stem Cell Research & Therapy
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
- (2017) Antonio Galleu et al. Science Translational Medicine
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
- (2017) Rafael Diaz de la Guardia et al. Stem Cell Reports
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR
- (2016) Elise A. Chong et al. BLOOD
- Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy
- (2016) R. Moschoi et al. BLOOD
- Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
- (2016) M. Sabatino et al. BLOOD
- Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche
- (2016) Haobin Ye et al. Cell Stem Cell
- T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
- (2016) Y. Kong et al. CLINICAL CANCER RESEARCH
- Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner
- (2016) Y. S. Al-Matary et al. HAEMATOLOGICA
- Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia
- (2016) Iman Mansour et al. Hematology
- The mitochondria target drug avocatin B synergizes with induction chemotherapeutics to induce leukemia cell death
- (2016) Matthew Tcheng et al. LEUKEMIA & LYMPHOMA
- Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions
- (2016) Adriana Borriello et al. Oncotarget
- Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
- (2016) Noureldien H.E. Darwish et al. Oncotarget
- Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung
- (2016) Kenneth Andrew Sinclair et al. Stem Cell Research & Therapy
- Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner
- (2016) Y. S. Al-Matary et al. HAEMATOLOGICA
- TLR4 plays a crucial role in MSC-induced inhibition of NK cell function
- (2015) Ying Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
- (2015) A. Ponzetta et al. CANCER RESEARCH
- Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia
- (2015) F. G. J. Calkoen et al. HAEMATOLOGICA
- Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
- (2015) C Krupka et al. LEUKEMIA
- The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro
- (2015) Jochen Vasold et al. LEUKEMIA RESEARCH
- Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
- (2015) Yoshikane Kikushige et al. ONCOLOGY
- The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk
- (2015) Kimberly H. Harrington et al. PLoS One
- PD-1hiTIM-3+ T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation
- (2015) Y Kong et al. Blood Cancer Journal
- Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia
- (2015) F. G. J. Calkoen et al. HAEMATOLOGICA
- Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
- (2015) Astrid Olsnes Kittang et al. OncoImmunology
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
- (2015) Valentina Folgiero et al. Oncotarget
- Cancer associated fibroblasts in hematological malignancies
- (2015) Lizzia Raffaghello et al. Oncotarget
- Acute Myelogenous Leukemia-Induced Sympathetic Neuropathy Promotes Malignancy in an Altered Hematopoietic Stem Cell Niche
- (2014) Maher Hanoun et al. Cell Stem Cell
- Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
- (2014) A Baragaño Raneros et al. GENES AND IMMUNITY
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
- (2013) F. Mussai et al. BLOOD
- Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling
- (2013) P. S. Hole et al. BLOOD
- Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment
- (2013) Holger Krönig et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V 2 T lymphocytes in non-Hodgkin lymphomas
- (2013) A. Musso et al. HAEMATOLOGICA
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- Correction: Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
- (2013) Jing Wang et al. PLoS One
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91phox expression and the PARP-1/PAR pathway of apoptosis
- (2012) J. Aurelius et al. BLOOD
- Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Friedrich Stölzel et al. TRANSPLANTATION
- CD73: a potent suppressor of antitumor immune responses
- (2012) Paul. A. Beavis et al. TRENDS IN IMMUNOLOGY
- Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
- (2011) Dirk Nagorsen et al. EXPERIMENTAL CELL RESEARCH
- Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
- (2011) Beatriz Sanchez-Correa et al. IMMUNOLOGY AND CELL BIOLOGY
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
- (2011) R. D. Michalek et al. JOURNAL OF IMMUNOLOGY
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
- (2011) M. Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells
- (2010) Elisabeth Ersvaer et al. BMC IMMUNOLOGY
- Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
- (2010) Zhang Shenghui et al. INTERNATIONAL JOURNAL OF CANCER
- Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
- (2009) R. Le Dieu et al. BLOOD
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+regulatory T cells
- (2008) N. Cools et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses
- (2007) Suzanne L. Tomchuck et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now